{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "15567896", "DateCompleted": {"Year": "2005", "Month": "05", "Day": "05"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "17"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "1386-0291", "JournalIssue": {"Volume": "31", "Issue": "4", "PubDate": {"Year": "2004"}}, "Title": "Clinical hemorheology and microcirculation", "ISOAbbreviation": "Clin Hemorheol Microcirc"}, "ArticleTitle": "Ganoderma lucidum suppresses endothelial cell cytotoxicity and proteinuria in persistent proteinuric focal segmental glomerulosclerosis (FSGS) nephrosis.", "Pagination": {"StartPage": "267", "EndPage": "272", "MedlinePgn": "267-72"}, "Abstract": {"AbstractText": ["A persistent proteinuria is commonly observed in nephrotic patient with focal segmental glomerulosclerosis (FSGS) under treatment with prednisolone+/-cyclophosphamide or with vasodilators (ACEI+AII receptor antagonist, calcium channel blocker and antiplatelet agent). Fourteen such patients with persistent proteinuria were subject to be treated with Ganoderma lucidum. Initial study revealed an enhanced endothelial cell cytotoxicity induced by patient's serum, and an altered immunocirculatory balance with predominant proinflammatory cytokine TNF alpha activity in the presence of defective anti-inflammatory cytokine interleukin-10. Treatment with Ganoderma lucidum suppressed endothelial cell cytotoxicity, restored immunocirculatory balance and successfully suppressed proteinuria in all of these 14 patients."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, King Chulalongkorn Memorial Hospital, Bangkok, Thailand. fmednft@md2.md.chula.ac.th"}], "Identifier": [], "LastName": "Futrakul", "ForeName": "Narisa", "Initials": "N"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Panichakul", "ForeName": "Tasanee", "Initials": "T"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Butthep", "ForeName": "Punnee", "Initials": "P"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Futrakul", "ForeName": "Prasit", "Initials": "P"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Jetanalin", "ForeName": "Pim", "Initials": "P"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Patumraj", "ForeName": "Suthiluk", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Siriviriyakul", "ForeName": "Prasong", "Initials": "P"}], "PublicationTypeList": ["Clinical Trial", "Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Clin Hemorheol Microcirc", "NlmUniqueID": "9709206", "ISSNLinking": "1386-0291"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "0", "NameOfSubstance": "Vasodilator Agents"}, {"RegistryNumber": "8N3DW7272P", "NameOfSubstance": "Cyclophosphamide"}, {"RegistryNumber": "9PHQ9Y1OLM", "NameOfSubstance": "Prednisolone"}], "MeshHeadingList": [{"QualifierName": ["therapeutic use"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": [], "DescriptorName": "Cell Death"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Cyclophosphamide"}, {"QualifierName": ["blood", "drug effects", "immunology"], "DescriptorName": "Cytokines"}, {"QualifierName": [], "DescriptorName": "Drug Therapy, Combination"}, {"QualifierName": ["drug effects", "pathology"], "DescriptorName": "Endothelial Cells"}, {"QualifierName": ["drug effects", "pathology"], "DescriptorName": "Endothelium, Vascular"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Glomerulosclerosis, Focal Segmental"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Nephritis, Interstitial"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Nephrosis"}, {"QualifierName": ["methods"], "DescriptorName": "Phytotherapy"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Prednisolone"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Proteinuria"}, {"QualifierName": [], "DescriptorName": "Reishi"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Vasodilator Agents"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2004", "Month": "11", "Day": "30", "Hour": "9", "Minute": "0"}, {"Year": "2005", "Month": "5", "Day": "6", "Hour": "9", "Minute": "0"}, {"Year": "2004", "Month": "11", "Day": "30", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["15567896"]}}], "PubmedBookArticle": []}